ClinicalTrials.govpublic full text
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
non small cell lung cancer, advanced solid tumor, metastatic melanoma, metastatic head and neck carcinoma, metastatic renal cell carcinoma, metastatic colorectal cancer, sarcomas, metastatic prostate cancer, ovarian cancer, small cell lung cancer, metastatic breast cancer, pancreas cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 894734
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.